Search

Australian scientists have today launched a world first research trial into a treatment that could prevent asthma in high risk children.

Two Australian scientists are spearheading an international campaign that's challenging the way asthma drugs are developed and tested.

One in eight children have asthma, a chronic disease of the airways in the lungs. It results in shortness of breath, chest tightness, wheezing and coughing.

A collaboration between The Kids Research Institute Australia and Joondalup Health Campus is poised to be a game-changer for early childhood development.

An ambitious project that could stop children developing asthma is the centrepiece of a new world-class respiratory research centre launched in Perth.

Researchers developing a world-first treatment that targets an underlying cause of asthma have secured a $499,640 grant from the Future Health, Research and Innovation Fund – Innovation Seed Fund.

Findings provide further proof of concept that pharmacological targeting of airway smooth muscle thickness will be beneficial and may be facilitated by azithromycin

This study is designed to identify the specific unique immune cell response that occurs in these children with recurrent disease.

Studies in Europe show exposure of pregnant women to high levels of microbial products stimulate immune function maturation in their offspring

The study aims to identify the mechanism for this so that this knowledge can be used to better treat asthma and allergies in both males and females.